Nuclear Medicine and Biology:

Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers. The importance of the target to an unmet clinical need should be the first consideration. If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.

If you are a member and experiencing difficulty accessing the journal online, please email Vidya Ramkumar [ussocieties(at)elsevier.com]. Vidya is our society liaison and typically responds in under 24 hours. You may also email our Executive Director, Charles Metzger [cmetzger(a)srsweb.org].